UPDATE: Goldman Sachs Downgrades Cohen & Steers to Sell on Sector Challenges

Loading...
Loading...
Goldman Sachs lowered its rating on Cohen & Steers
CNS
from Hold to Buy and reduced its price target from $31 to $26.50. Goldman Sachs noted, "We believe CNS shares will underperform (both absolute and relative) as investors contemplate: (1) growing “indexation” of real estate mutual funds amid gains from ETFs; (2) slipping 3-year performance numbers and slower open-end mutual fund flows; (3) recent dividend cuts in Japanese sub-advised funds driving outflows and an adverse fee mix shift. Still, CNS trades at 20X NTM P/E, a significant premium to the group's 14X, and we see 21% downside." Cohen & Steers closed at $33.71 on Tuesday.
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorDowngradesPrice TargetPre-Market OutlookAnalyst RatingsGoldman Sachs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...